# Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors

> **NCT00004864** · PHASE1 · COMPLETED · sponsor: **Montefiore Medical Center**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** GEM 231
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00004864
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2000-06
- **Final completion:** 2000-06
- **Target enrollment:** — (—)
- **Last updated:** 2018-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004864

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004864, "Docetaxel and GEM 231 in Treating Patients With Recurrent or Refractory Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00004864. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*